Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat
Preclinical studies suggest retatrutide may modulate cancer-related metabolic pathways
Sexual health From low libido to birth control, Hers handles the downstairs department with zero judgment
JAMA 2023, 330, 16311640
US$ 24.34
US$ 27.72
US$ 29.02
US$ 25.40
US$ 24.33
